D. Lee

High‐dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC‐3) results in high first‐cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia

S. Opat, A. Schwarer, S. Avery, 2013, Internal medicine journal.

Monoclonal antibodies: a new era in the treatment of non-Hodgkin's lymphoma.

Antonio J. Grillo-López, P. Multani, C. White, 2001, Current pharmaceutical biotechnology.

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

T. Cascino, J. Buckner, D. Macdonald, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cost Effectiveness of Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for the First-Line Treatment of Mantle Cell Lymphoma not Eligible for Stem Cell Transplantation: a Scottish Perspective.

M. van Keep, K. Gairy, D. Seshagiri, 2015, Value in Health.

Real-World Transitions from Parenteral, Inhaled, and Oral Prostacyclin-Class Therapies to Oral Treprostinil: Interim Data from the ADAPT Registry

A. Ravichandran, K. Parikh, S. Sahay, 2020 .